相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in bone mass associated with obesity and weight loss in humans: Applicability of animal models
Vivi F. H. Jensen et al.
BONE (2021)
Lycopene ameliorates diabetic osteoporosis via anti-inflammatory, anti-oxidation, and increasing Osteoprotegerin/RANKL expression ratio
Shan Shan Qi et al.
JOURNAL OF FUNCTIONAL FOODS (2021)
Comparison of differences in bone microarchitecture in adult- versus juvenile-onset type 1 diabetes Asian males versus non-diabetes males: an observational cross-sectional pilot study
Lingling Xu et al.
ENDOCRINE (2021)
Elevated HbA1c Is Associated with Altered Cortical and Trabecular Microarchitecture in Girls with Type 1 Diabetes
Deborah M. Mitchell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Proteomic and Transcriptomic Approaches for Studying Bone Regeneration in Health and Systemically Compromised Conditions
Elena Calciolari et al.
PROTEOMICS CLINICAL APPLICATIONS (2020)
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Jennifer R. Snaith et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production
Kevan C. Herold et al.
DIABETES OBESITY & METABOLISM (2020)
Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R
Ziyi Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Glucose-Lowering Drugs and Fracture Risk-a Systematic Review
Z. Al-Mashhadi et al.
CURRENT OSTEOPOROSIS REPORTS (2020)
Pharmacologic treatment options for type 1 diabetes: what's new?
Laura M. Nally et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Liang Cheng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2019)
Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
Guillaume Mabilleau et al.
JOURNAL OF ENDOCRINOLOGY (2018)
Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: A systematic review and meta-analysis
Eleanor P. Thong et al.
CLINICAL ENDOCRINOLOGY (2018)
Liraglutide exerts a bone-protective effect in ovariectomized rats with streptozotocin-induced diabetes by inhibiting osteoclastogenesis
Binhong Wen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials
Y. S. Zhang et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats
Shanshan Qi
BIOLOGICAL TRACE ELEMENT RESEARCH (2018)
The effect of experimental diabetes and glycaemic control on guided bone regeneration: histology and gene expression analyses
M. Retzepi et al.
CLINICAL ORAL IMPLANTS RESEARCH (2018)
Mechanisms of diabetes mellitus-induced bone fragility
Nicola Napoli et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis
Katrine Hygum et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes
Anna K. Ryden et al.
JOURNAL OF AUTOIMMUNITY (2017)
Osteocyte Mechanobiology
Yuhei Uda et al.
CURRENT OSTEOPOROSIS REPORTS (2017)
Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts
Evangelia Kalaitzoglou et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice
Takashi Hatanaka et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2016)
Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice
M. Pereira et al.
BONE (2015)
Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus
Sity Aishah Mansur et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials
Bin Su et al.
ENDOCRINE (2015)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
Xue Ma et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Both spontaneous Ins2+/- and streptozotocin-induced type I diabetes cause bone loss in young mice
Lindsay M. Coe et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
The use of animal models in diabetes research
Aileen J. F. King
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Weight loss, weight regain and bone health
Amos Pines
CLIMACTERIC (2012)
High Levels of Tumor Necrosis Factor-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing
Jazia Alblowi et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus
John L. Fowlkes et al.
ENDOCRINOLOGY (2008)
Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats
Mamiko Hie et al.
BONE (2007)
Inhibition of PPARγ prevents type I diabetic bone marrow adiposity but not bone loss
Sergiu Rotolin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Normal bone density obtained in the absence of insulin receptor expression in bone
Regina Irwin et al.
ENDOCRINOLOGY (2006)
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
J Paloneva et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation
HF Lu et al.
ENDOCRINOLOGY (2003)
分享论文
